Inventor · disambiguated record
David J. Maloney
Also filed as: ARBUCKLE JESSE · MALONEY DAVID · MALONEY DAVID J · MALONEY DAVID JOSEPH
23 granted patents·7 pending applications·41 citations·filing 2006–2024
93Inventor score
Files withUS HEALTH9BELLBROOK LABS LLC3CONVERGENE LLC3EASTERN VIRGINIA MEDICAL SCHOOL3ARNER ELIAS SET JENOE2
Top patents by PatentIndex Score
30 records- 0194US11247971B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2021·Granted Feb 15, 2022·3 cites·17 claims
- 0290US10961200B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofTHE US SECRETARY DEPARTMENT OF HEALTH·Filed 2019·Granted Mar 30, 2021·4 cites·18 claims
- 0389US10351532B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUNIV VANDERBILT·Filed 2015·Granted Jul 16, 2019·8 cites·21 claims
- 0486US12365653B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2024·Granted Jul 22, 2025·0 cites·12 claims
- 0585US10899710B2Pyridines and their use in the treatment of cancerUS HEALTH·Filed 2016·Granted Jan 26, 2021·4 cites·20 claims
- 0684US10266488B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2014·Granted Apr 23, 2019·3 cites·9 claims
- 0782US10508106B2Bicyclic BET bromodomain inhibitors and uses thereofCONVERGENE LLC·Filed 2016·Granted Dec 17, 2019·2 cites·2 claims
- 0881US11274077B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2020·Granted Mar 15, 2022·1 cites·20 claims
- 0980US7605241B2Synthesis of inhibitors of p90RskUNIV VIRGINIA·Filed 2006·Granted Oct 20, 2009·4 cites·6 claims
- 1079US9802904B2Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereofUS HEALTH·Filed 2013·Granted Oct 31, 2017·4 cites·4 claims
- 1177US10752581B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2019·Granted Aug 25, 2020·1 cites·13 claims
- 1276US11897845B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2022·Granted Feb 13, 2024·0 cites·19 claims
- 1375US8871789B2Method of preventing or treating viral infectionUS HEALTH·Filed 2013·Granted Oct 28, 2014·5 cites·26 claims
- 1473US10954228B21 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereofNAT INSTITUTES OF HEALTH UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Mar 23, 2021·2 cites·18 claims
- 1565US11795177B2Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitorsUS HEALTH·Filed 2022·Granted Oct 24, 2023·0 cites·22 claims
- 1658US11028079B2Small molecule BET bromodomain inhibitors and uses thereofCONVERGENE LLC·Filed 2019·Granted Jun 8, 2021·0 cites·14 claims
- 1758US2025066345A1Compositions and methods of use to treat 12-lipoxygenase (12-lox) mediated diseasesVERALOX THERAPEUTICS·Filed 2022·Application pending·0 cites
- 1857US2025057857A1Aqueous parenteral pharmaceutical formulations containing 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivativesVERALOX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1956US8426568B2Rhamnose substituents of SL0101 and therapeutic uses thereofSMITH JEFFREY A·Filed 2007·Granted Apr 23, 2013·0 cites·2 claims
- 2054US11505559B2Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitorsUS HEALTH·Filed 2018·Granted Nov 22, 2022·0 cites·18 claims
- 2153US11426415B2Treatment for Wolfram syndrome and other endoplasmic reticulum stress disordersUNIV WASHINGTON·Filed 2018·Granted Aug 30, 2022·0 cites·11 claims
- 2252US2024174684A1INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTSBELLBROOK LABS LLC·Filed 2022·Application pending·0 cites
- 2350US2011207784A1Oxadiazole-2-oxides as antischistosomal agentsUS HEALTH·Filed 2009·Application pending·0 cites
- 2448US12497395B2Small molecule bromodomain inhibitors and uses therofCONVERGENE LLC·Filed 2020·Granted Dec 16, 2025·0 cites·13 claims
- 2542US2022073532A1Inhibitors of cgas activity as therapeutic agentsBELLBROOK LABS LLC·Filed 2020·Application pending·0 cites
- 2642US2022073470A1Inhibitors of cgas activity as therapeutic agentsBELLBROOK LABS LLC·Filed 2020·Application pending·0 cites
- 2735US2013096159A1Inhibitors of human 12-lipoxygenaseMALONEY DAVID J·Filed 2011·Application pending·0 cites
- 2834US10881653B2Tricyclic compounds and their use in the treatment of cancerARNER ELIAS SET JENOE·Filed 2016·Granted Jan 5, 2021·0 cites·18 claims
- 2932US10287279B2Inhibitors of human 12/15-lipoxygenaseMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted May 14, 2019·0 cites·19 claims
- 3028US11110089B2Pyridazinones and their use in the treatment of cancerARNER ELIAS SET JENOE·Filed 2016·Granted Sep 7, 2021·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when David J. Maloney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →